DJIA 17,721.23 101.72 0.58%
NASDAQ 5,008.91 22.05 0.44%
S&P 500 2,071.55 8.44 0.41%
market minute promo


23.76 -0.66 (-2.70%)

Quote as of

company name or ticker

Recent Quotes

INSM $23.76 -2.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.96
Previous Close $24.42
Daily Range $23.43 - $25.30
52-Week Range $11.25 - $25.39
Market Cap $1.5B
P/E Ratio -12.03
Dividend (Yield) $0.00 (0.0%)
Volume 284,871
Average Daily Volume 380,135
Current FY EPS -$2.01




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

See More INSM News...

INSM's Top Competitors

INSM $23.76 (-2.70%)
Current stock: INSM
AMGN $153.89 (0.24%)
Current stock: AMGN
GILD $115.60 (-1.26%)
Current stock: GILD
BIIB $404.61 (0.17%)
Current stock: BIIB